SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001453687-22-000069
Filing Date
2022-04-28
Accepted
2022-04-28 07:45:10
Documents
15
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A selb-20211231.htm   iXBRL 10-K/A 828038
2 EX-31.3 exhibit313_04282022.htm EX-31.3 5849
3 EX-31.4 exhibit314_04282022.htm EX-31.4 5653
  Complete submission text file 0001453687-22-000069.txt   1155759

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT selb-20211231.xsd EX-101.SCH 2552
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT selb-20211231_lab.xml EX-101.LAB 39794
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT selb-20211231_pre.xml EX-101.PRE 21068
9 EXTRACTED XBRL INSTANCE DOCUMENT selb-20211231_htm.xml XML 19386
Mailing Address 65 GROVE STREET WATERTOWN MA 02472
Business Address 65 GROVE STREET WATERTOWN MA 02472 617-923-1400
SELECTA BIOSCIENCES INC (Filer) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37798 | Film No.: 22862262
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences